Brain & Nervous System Health Center
This article is from the WebMD News Archive
Multiple Sclerosis Rates Up 50%
Jan. 29, 2007 -- Multiple sclerosis (MS)Multiple sclerosis (MS)may be 50% more common in the U.S. than previously thought, according to a new research review.
The review from the National Institute of Neurological Disorders and Stroke says almost one in 1,000 people in the U.S. have MS.
However, the National Multiple Sclerosis Society says that figure could still be low.
The society points out that the review's estimate of MS prevalence (the number of people with MS) works out to about 266,000 people.
But the society says it has "over 300,000 people" in its database who say they have MS.
The Review
The review's researchers included Deborah Hirtz, MD, of the National Institute of Neurological Disorders and Stroke, which is part of the National Institutes of Health (NIH).
They analyzed 500 studies published from 1990 to 2005 to track MS and 11 other neurological disorders. Their findings appear in the Jan. 30 issue of Neurology.
Since high-quality U.S. data on most disorders were lacking, the researchers often applied data from other countries to the U.S. population.
That approach isn't ideal, the researchers admit. They call for better studies to track neurological disorders in the U.S.
Still, they say their findings show "the burden of neurologic illness affects many millions of people in the United States."
Multiple Sclerosis Findings
"Our estimate of MS prevalence is about 50% higher than a comprehensive review from 1982," Hirtz says in an American Academy of Neurology news release.
"Whether this reflects improvement in diagnosis or whether incidence is actually increasing deserves further study," Hirtz says.
How Common Are Neurological Conditions?
In addition to MS, the researchers tracked the prevalence of the following conditions:
- Migraine: 121 in 1,000 people
- EpilepsyEpilepsy: 7.1 in 1,000 people
- Alzheimer's diseaseAlzheimer's disease:67 in 1,000 people 65 or older
- Parkinson's diseaseParkinson's disease: 9.5 in 1,000 people 65 or older
- AutismAutismspectrum disorders: 5.8 in 1,000 children
- Cerebral palsyCerebral palsy:2.4 in 1,000 children
- Stroke: 10 per 1,000 people
- Traumatic brain injury: No prevalence estimates available
- MS: 0.9 in 1,000 people
- Spinal cord injury: No prevalence estimates available
- ALSALS(amyotrophic lateral sclerosis, or Lou Gehrig's disease): 0.04 in 1,000 people
- Tourette's syndrome: No prevalence estimates
Conditions Not Tracked
These conditions aren't necessarily the most common neurological disorders, note Hirtz and colleagues.
For instance, they didn't track sleep disorderssleep disorders, chronic pain, or mental retardation.
And though autismautism and cerebral palsycerebral palsy are lifelong conditions, data were only available for cases in children.
Important Safety Information
Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information

